News

Article

Vetter Prepares to Further Increase Production Capacity and Services at Austrian Site

Author(s):

Vetter is further expanding its production capacity and services at its Rankweil, Austria site.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - stock.adobe.com

Cagkan - stock.adobe.com

Global contract development and manufacturing organization, Vetter, has announced its plans to further expand its production capacity and services at its Rankweil, Austria site, in response to increased market demand.

According to a May 9, 2023 press release, the company will be implementing additional equipment for aseptic production and will be expanding the storage capacity at the clinical site based in Austria. A second autoclave and washing machine for material preparation will be implemented to expand cleanroom utilization. Additional freezers are also being purchased to improve cold storage capacity.

Further, Vetter will also be able to process powdered substances at the Rankweil site thanks to the implementation of an isolator, and the clinical filling portfolio is set to be expanded with a greater number of options for primary packaging materials. With these plans for expansion, the company believes that it will be able to increase the production volume of the facility by more than double in 2023 when compared with 2022.

“In addition to our existing clinical manufacturing facility in Chicago, Rankweil has established itself in a very short time as a strategically important location for us and our partners,” said Claus Feussner, senior vice-president, Vetter Development Service, in the press release. “Customer service, efficient processes, and our high-quality standard are the focus.”

Source: Vetter

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content